These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22444683)

  • 1. A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation.
    Graham TH; Liu W; Verras A; Sebhat IK; Xiong Y; Bleasby K; Bhatt UR; Chen Q; Garcia-Calvo M; Geissler WM; Gorski JN; He H; Lassman ME; Lisnock J; Li X; Shen Z; Tong X; Tung EC; Wiltsie J; Xiao J; Xie D; Xu S; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2811-7. PubMed ID: 22444683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes.
    Graham TH; Liu W; Verras A; Reibarkh M; Bleasby K; Bhatt UR; Chen Q; Garcia-Calvo M; Geissler WM; Gorski JN; He H; Lassman ME; Lisnock J; Li X; Shen Z; Tong X; Tung EC; Wiltsie J; Xie D; Xu S; Xiao J; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2818-22. PubMed ID: 22444685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitors.
    Shen HC; Ding FX; Zhou C; Xiong Y; Verras A; Chabin RM; Xu S; Tong X; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Geissler W; Shen Z; Chen D; Sinharoy R; Hale JJ; Tata JR; Pinto S; Shen DM; Colletti SL
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1299-305. PubMed ID: 21315588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.
    Debenham JS; Graham TH; Verras A; Zhang Y; Clements MJ; Kuethe JT; Madsen-Duggan C; Liu W; Bhatt UR; Chen D; Chen Q; Garcia-Calvo M; Geissler WM; He H; Li X; Lisnock J; Shen Z; Tong X; Tung EC; Wiltsie J; Xu S; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6228-33. PubMed ID: 24157366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanine.
    Wu Z; Yang C; Xiong Y; Feng Z; Lombardo M; Verras A; Chabin RM; Xu S; Tong X; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Geissler W; Shen Z; Chen Q; Sinharoy R; Hale JJ; Tata JR; Pinto S; Shen DM; Colletti SL
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1774-8. PubMed ID: 22248857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitors.
    Shen HC; Ding FX; Jiang J; Verras A; Chabin RM; Xu S; Tong X; Chen Q; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Geissler W; Shen Z; Murphy BA; Gorski JN; Wiltsie J; SinhaRoy R; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1550-6. PubMed ID: 22264488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors.
    Wu Z; Yang C; Graham TH; Verras A; Chabin RM; Xu S; Tong X; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Shen Z; Chen Q; Bleasby K; Sinharoy R; Hale JJ; Tata JR; Pinto S; Colletti SL; Shen DM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1727-30. PubMed ID: 22290078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors.
    Graham TH; Shen HC; Liu W; Xiong Y; Verras A; Bleasby K; Bhatt UR; Chabin RM; Chen D; Chen Q; Garcia-Calvo M; Geissler WM; He H; Lassman ME; Shen Z; Tong X; Tung EC; Xie D; Xu S; Colletti SL; Tata JR; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):658-65. PubMed ID: 22079761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity.
    Zhou C; Garcia-Calvo M; Pinto S; Lombardo M; Feng Z; Bender K; Pryor KD; Bhatt UR; Chabin RM; Geissler WM; Shen Z; Tong X; Zhang Z; Wong KK; Roy RS; Chapman KT; Yang L; Xiong Y
    J Med Chem; 2010 Oct; 53(19):7251-63. PubMed ID: 20857914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.
    Sun S; Dean R; Jia Q; Zenova A; Zhong J; Grayson C; Xie C; Lindgren A; Samra P; Sojo L; van Heek M; Lin L; Percival D; Fu JM; Winther MD; Zhang Z
    Bioorg Med Chem; 2013 Dec; 21(24):7724-34. PubMed ID: 24211162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors.
    Graham TH; Shu M; Verras A; Chen Q; Garcia-Calvo M; Li X; Lisnock J; Tong X; Tung EC; Wiltsie J; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1657-60. PubMed ID: 24636945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
    Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review.
    Graham TH
    Expert Opin Ther Pat; 2017 Oct; 27(10):1077-1088. PubMed ID: 28699813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent and orally bioavailable 17β-hydroxysteroid dehydrogenase type 3 inhibitors.
    Harada K; Kubo H; Abe J; Haneta M; Conception A; Inoue S; Okada S; Nishioka K
    Bioorg Med Chem; 2012 May; 20(10):3242-54. PubMed ID: 22512907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.
    Lachance N; Gareau Y; Guiral S; Huang Z; Isabel E; Leclerc JP; Léger S; Martins E; Nadeau C; Oballa RM; Ouellet SG; Powell DA; Ramtohul YK; Tranmer GK; Trinh T; Wang H; Zhang L
    Bioorg Med Chem Lett; 2012 Jan; 22(2):980-4. PubMed ID: 22209206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines.
    Bosanac T; Hickey ER; Ginn J; Kashem M; Kerr S; Kugler S; Li X; Olague A; Schlyer S; Young ER
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3746-9. PubMed ID: 20471253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
    Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3.
    Harikrishnan LS; Kamau MG; Wan H; Inghrim JA; Zimmermann K; Sang X; Mastalerz HA; Johnson WL; Zhang G; Lombardo LJ; Poss MA; Trainor GL; Tokarski JS; Lorenzi MV; You D; Gottardis MM; Baldwin KF; Lippy J; Nirschl DS; Qiu R; Miller AV; Khan J; Sack JS; Purandare AV
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1425-8. PubMed ID: 21282055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.
    Cheng H; Hoffman J; Le P; Nair SK; Cripps S; Matthews J; Smith C; Yang M; Kupchinsky S; Dress K; Edwards M; Cole B; Walters E; Loh C; Ermolieff J; Fanjul A; Bhat GB; Herrera J; Pauly T; Hosea N; Paderes G; Rejto P
    Bioorg Med Chem Lett; 2010 May; 20(9):2897-902. PubMed ID: 20363126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene series.
    Lethu S; Ginisty M; Bosc D; Dubois J
    J Med Chem; 2009 Oct; 52(20):6205-8. PubMed ID: 19772293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.